Most Recent

image: Cancer's Vanguard

Cancer's Vanguard

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Cancerous Conduits

Cancerous Conduits

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Tumor Traps

Tumor Traps

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: A Different Way of Doing Things

A Different Way of Doing Things

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Metabolic Reprogramming

Metabolic Reprogramming

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: The Forces of Cancer

The Forces of Cancer

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Under Pressure

Under Pressure

By | April 1, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

image: Zika Infects Neural Progenitors

Zika Infects Neural Progenitors

By | March 4, 2016

Exosomes are emerging as key players in metastasis.

2 Comments

image: Amoebae Have Human-Like Immunity

Amoebae Have Human-Like Immunity

By | March 2, 2016

Exosomes are emerging as key players in metastasis.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech